End-user Segment Analysis: Women (Largest & Fastest-Growing Segment)

The women segment held the largest share of the infertility drugs market, accounting for 69.53% share in 2026, and is also expected to represent the fastest-growing end-user segment, reflecting the substantial role of female-focused pharmacological interventions throughout infertility treatment. Drug therapies are widely used to support ovulation induction, regulate reproductive processes, and improve the likelihood of conception across different assisted and non-assisted fertility treatment pathways. Increasing awareness of available infertility treatments and greater willingness to seek medical support for reproductive challenges are contributing to demand among women. The expansion of fertility care services and improvements in diagnostic capabilities are also enabling more patients to receive individualized treatment based on underlying reproductive conditions. In addition, changing family-planning patterns and the growing tendency to pursue pregnancy at later stages of life are increasing the importance of effective fertility management. Continued innovation in hormonal therapies and treatment protocols is therefore supporting both the established market position and growth prospects of the women end-user segment.

Distribution Channel Segment Analysis: Hospital Pharmacies (Largest Segment) vs Online Pharmacies (Fastest-Growing Segment)

Hospital pharmacies represented the largest distribution channel in the infertility drugs market, holding 57.11% share in 2026, supported by the specialized nature of fertility treatment and the close involvement of healthcare professionals in medication selection and administration. Infertility therapies often require individualized dosing, clinical monitoring, and coordination with diagnostic and assisted reproductive procedures, making hospital-linked pharmacy services particularly important for treatment continuity. Hospital pharmacies can also facilitate access to specialized medicines while enabling healthcare teams to monitor treatment response and modify therapeutic approaches when necessary. The concentration of fertility expertise within hospitals and specialized reproductive care centers further strengthens this channel. As fertility treatment increasingly relies on coordinated clinical pathways, hospital pharmacies continue to serve as a trusted and integrated source for infertility medications.

Online pharmacies are anticipated to grow at the fastest pace as consumers increasingly seek convenient and discreet ways to obtain prescription medicines associated with ongoing fertility treatment. Digital purchasing channels can reduce the need for repeated physical pharmacy visits and provide greater accessibility for patients managing extended treatment schedules. The expansion of digital healthcare services, improved online ordering infrastructure, and increasing consumer familiarity with e-pharmacy platforms are supporting this transition. Privacy and convenience can be particularly relevant in fertility care, where patients may prefer more discreet medication procurement. As healthcare delivery becomes increasingly connected with digital commerce and remote support services, online pharmacies are gaining importance as an additional distribution pathway for infertility drugs, particularly among patients seeking greater flexibility during treatment.